FORTY SEVEN
Forty Seven, Inc. is a clinical-stage immuno-oncology company that is developing therapies targeting cancer immune evasion pathways based on technology licensed from Stanford University. Forty Seven's lead program, 5F9, is a monoclonal antibody against the CD47 receptor, a "don't eat me" signal that cancer cells commandeer to avoid being ingested by macrophages. This antibody is currently being evaluated in six clinical studies in patients with solid tumors, acute myeloid leukemia, non-Hodgkin's lymphoma and colorectal carcinoma.
FORTY SEVEN
Industry:
Biotechnology Clinical Trials Health Care
Founded:
2015-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.fortyseveninc.com
Total Employee:
51+
Status:
Closed
Contact:
650-352-4150
Total Funding:
156 M USD
Technology used in webpage:
SPF LetsEncrypt Microsoft Exchange Online Office 365 Mail IPv6 ReCAPTCHA Microsoft Azure DNS COVID-19 ReCAPTCHA V2 Pound Sterling
Current Advisors List
Board_member
2015-01-01
Board_member
2018-01-01
Board_member
2015-01-01
Current Employees Featured
Irving L. Weissman Founder @ Forty Seven
Founder
2014-10-14
Jens-Peter Volkmer Founder & VP Research & Early Development @ Forty Seven
Founder & VP Research & Early Development
Mark McCamish President and Chief Executive Officer @ Forty Seven
President and Chief Executive Officer
2017-05-01
Norman Kruse Chief Patent Counsel @ Forty Seven
Chief Patent Counsel
2015-10-01
Ravi Majeti Founder @ Forty Seven
Founder
2015-01-01
Ann D. Rhoads Chief Financial Officer @ Forty Seven
Chief Financial Officer
Founder
Stock Details
Investors List
Leukemia & Lymphoma Society
Leukemia & Lymphoma Society investment in Post-IPO Equity - Forty Seven
Wellington Management
Wellington Management investment in Series B - Forty Seven
Sutter Hill Ventures
Sutter Hill Ventures investment in Series B - Forty Seven
Clarus Ventures
Clarus Ventures investment in Series B - Forty Seven
GV
GV investment in Series B - Forty Seven
Lightspeed Venture Partners
Lightspeed Venture Partners investment in Series B - Forty Seven
Lightspeed Venture Partners
Lightspeed Venture Partners investment in Series A - Forty Seven
Sutter Hill Ventures
Sutter Hill Ventures investment in Series A - Forty Seven
GV
GV investment in Series A - Forty Seven
Clarus Ventures
Clarus Ventures investment in Series A - Forty Seven
Official Site Inspections
http://www.fortyseveninc.com
- Host name: 40.70.27.35
- IP address: 40.70.27.35
- Location: Boydton United States
- Latitude: 36.6534
- Longitude: -78.375
- Metro Code: 560
- Timezone: America/New_York
- Postal: 23917
More informations about "Forty Seven"
Forty Seven - Crunchbase Company Profile & Funding
Forty Seven, Inc. is a clinical-stage immuno-oncology company that is developing therapies targeting cancer immune evasion pathways based on technology licensed from Stanford University. Forty Seven's lead program, 5F9, is a …See details»
Forty Seven Company Profile 2024: Valuation, Investors …
Forty Seven General Information Description. Developer of immuno-oncology therapies intended to activate macrophages intended to fight cancer. The company engages in the development of therapies based on anti-CD47 which …See details»
Forty Seven - Craft
Mar 3, 2020 Forty Seven, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights. Mar 20, 2020. Forty Seven and Rocket Pharmaceuticals …See details»
Forty Seven Inc. - LinkedIn
Forty Seven Inc. | 5,935 followers on LinkedIn. Helping Patients Defeat Their Cancer | With a passion for helping patients defeat their cancer, we are committed to the advancement of …See details»
Management | Forty Seven, Inc.
The Investor Relations website contains information about Forty Seven, Inc. 's business for stockholders, potential investors, and financial analysts.See details»
SEC Filing | Forty Seven, Inc.
Name of Issuer; Forty Seven, Inc. Street Address 1 Street Address 2; 1490 O'BRIEN DRIVE, Suite A: City State/Province/Country ZIP/PostalCode Phone Number of IssuerSee details»
Forty Seven Inc Company Profile - Forty Seven Inc Overview
Forty Seven Inc (Forty Seven), formerly CD47 Sciences Inc is a clinical-stage immuno-oncology company that focuses on the development of therapies to treat cancer. The company’s lead …See details»
Forty Seven Inc. Overview | SignalHire Company Profile
To connect with Forty Seven Inc. employee register on SignalHire. Organization Website: fortyseveninc.com : Social Links: Phone Number: 1-650-352-4150: Forty Seven Inc. industries …See details»
Company Forty Seven, Inc. - MarketScreener.com
Apr 6, 2020 Forty Seven, Inc. is clinical-stage immuno-oncology company. The Company is focused on developing novel checkpoint therapies to activate macrophages in the fight against …See details»
Board of Directors - Forty Seven, Inc.
The Investor Relations website contains information about Forty Seven, Inc. 's business for stockholders, potential investors, and financial analysts.See details»
Forty Seven - Company Profile - Tracxn
Dec 9, 2024 Forty Seven, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business HighlightsSeeking Alpha • Mar 20, 2020 • Forty Seven WeissLaw LLP …See details»
Forty Seven Company Profile | Management and Employees List
Forty - Seven Inc. Primary Industries. Internet Service Providers, Website Hosting & Internet-related Services Telecommunications Hospitality Restaurants. Contact Information. …See details»
Forty Seven, Inc. Company Profile | Foster City, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Forty Seven, Inc. of Foster City, CA. Get the latest business insights from Dun & Bradstreet.See details»
Gilead to Acquire Forty Seven for $4.9 Billion - Gilead Sciences
Mar 2, 2020 Forty Seven, Inc. is a clinical-stage immuno-oncology company that is developing therapies targeting cancer immune evasion pathways and specific cell targeting approaches …See details»
EIN 47-4065674 - Forty Seven, Inc., Menlo Park, California - EIN TaxId
Organization Name: Forty Seven, Inc. IRS EIN (Taxpayer Id) 47-4065674: Doing Business As: Forty Seven Inc: Type of business: Pharmaceutical Preparations: Business Address and …See details»
Forty Seven - Products, Competitors, Financials, Employees ...
Football club AC Roma’s non-profit organization Roma Cares is similarly supported. Roma Cares was founded in 2014 with the aim of promoting education and positive values through sports. …See details»
FORTY SEVEN, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for FORTY SEVEN, INC. of Palo Alto, CA. Get the latest business insights from Dun & Bradstreet.See details»
Forty Seven CEO and Key Executive Team | Craft.co
Forty Seven's President & Chief Executive Officer is Mark McCamish. Other executives include Chris H. Takimoto, Chief Medical Officer; Ann D. Rhoads, CFO and 6 others. See the full …See details»
Forty Seven Inc. Appoints Ian T. Clark to Board of Directors
MENLO PARK, Calif., April 30, 2018 /PRNewswire/ -- Forty Seven Inc., a clinical-stage company focused on developing checkpoint therapies to activate macrophages in the fight against …See details»
Fortyseven - Overview, News & Similar companies | ZoomInfo.com
Apr 10, 2020 The Hoyt Organization <25 <$5M. 2. PR Media <25 <$5M. 3. GroundFloor Media. 84. $6.5M. 4. Engage Media Communications <25 <$5M. 5. The Brack Group <25. $5.8M. 6. …See details»